BRASILIA, (Reuters) - Brazil approved yesterday human clinical trials for a potential COVID-19 vaccine developed by Johnson & Johnson, the fourth candidate to trial in the Latin American country that has become key to the global race for a vaccine.
The article Brazil greenlights human trials for J&J’s potential COVID-19 vaccine appeared first on Stabroek News.
